Sanofi-GSK reports success in Covid vaccine, after setback

Sanofi and GlaxoSmithKline’s potential Covid-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join th...